Corey Davis

COREY DAVIS joined Hambrecht & Quist in 1997 covering the emerging
pharmaceutical industry with an emphasis on mid-cap emerging pharma
names like Alza, Forest, Shire, King, and Medicis. Mr. Davis also
focuses on drug delivery and specialty firms like Emisphere and Neose.
He also co-covers with Alex Zisson the big-cap pharmaceuticals such as
Lilly, Schering-Plough, Merck, Pfizer, and Glaxo. Prior to joining H&Q,
Mr. Davis received a PhD in Molecular Biology from Princeton University.
He graduated Magna Cum Laude in 1991 with High Honors in Biology from
Middlebury College, where he was elected to Phi Beta Kappa.